A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Stopped early · Phase 2
Conditions studied: Small Cell Lung Carcinoma
In brief
This study will summarize the safety of patients receiving figitumumab combined with etoposide and cisplatin (or carboplatin) vs. patients receiving etoposide and cisplatin (or carboplatin) alone as first line treatment for extensive stage disease Small Cell Lung Cancer.
Key facts
- Study ID
- NCT00977561
- Run by
- Pfizer
- People needed
- 9
- Starts
- 2010-04-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2013-02-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed diagnosis of extensive stage disease Small Cell Lung Cancer (SCLC), with tumor biopsy sample required.
- Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. Total IGF-1 > or = 120 ng/ml
You may not qualify if…
- Any prior systemic therapy for Small Cell Lung Cancer (SCLC)
- HbA1c > or = 5.7%
Where it is running
- Pfizer Investigational Site — Washington D.C., District of Columbia, United States
- Pfizer Investigational Site — Marrero, Louisiana, United States
- Pfizer Investigational Site — Metairie, Louisiana, United States
- Pfizer Investigational Site — City of Saint Peters, Missouri, United States
- Pfizer Investigational Site — Creve Coeur, Missouri, United States
- Pfizer Investigational Site — St Louis, Missouri, United States
- Pfizer Investigational Site — St Louis, Missouri, United States
- Pfizer Investigational Site — Morristown, New Jersey, United States
- Pfizer Investigational Site — Hickory, North Carolina, United States
- Pfizer Investigational Site — Kernersville, North Carolina, United States
- Pfizer Investigational Site — Lenoir, North Carolina, United States
- Pfizer Investigational Site — Lexington, North Carolina, United States
- Pfizer Investigational Site — Mount Airy, North Carolina, United States
- Pfizer Investigational Site — North Wilkesboro, North Carolina, United States
- Pfizer Investigational Site — Winston-Salem, North Carolina, United States
- Pfizer Investigational Site — Beaverton, Oregon, United States
- Pfizer Investigational Site — Gresham, Oregon, United States
- Pfizer Investigational Site — Portland, Oregon, United States
- Pfizer Investigational Site — Portland, Oregon, United States
- Pfizer Investigational Site — Tualatin, Oregon, United States
- Pfizer Investigational Site — West Reading, Pennsylvania, United States
- Pfizer Investigational Site — Christiansburg, Virginia, United States
- Pfizer Investigational Site — Low Moor, Virginia, United States
- Pfizer Investigational Site — Roanoke, Virginia, United States
- Pfizer Investigational Site — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.